Pharmacokinetic population study to describe cefepime lung concentrations

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Pharmacokinetics

Background:

• Cefepime is a broad-spectrum cephalosporin antibiotic used to treat various bacterial infections.
• Understanding cefepime's distribution into lung tissue is crucial for optimizing its efficacy in respiratory tract infections.
• Previous studies have not fully elucidated the pharmacokinetic parameters of cefepime within lung tissue.

Purpose of the Study:

• To quantify cefepime lung diffusion by comparing lung and serum concentrations.
• To estimate population pharmacokinetic parameters of cefepime in lung tissue.
• To assess the rate and extent of cefepime penetration into lung tissue.

Main Methods:

• A pharmacokinetic study involving 16 patients undergoing lung surgery for bronchial epithelioma.
• Cefepime concentrations in serum and lung tissue were measured using High-Performance Liquid Chromatography (HPLC) with UV detection.
• A two-compartment population pharmacokinetic model was developed using NONMEM to analyze the data.

Main Results:

• The mean concentration ratio of cefepime between lung and serum was approximately 101%, indicating similar concentrations.
• Cefepime demonstrated rapid diffusion into lung tissue without a significant lag time.
• Key pharmacokinetic parameters including volume of distribution, clearance, and transfer constants were estimated.

Conclusions:

• Cefepime achieves excellent penetration into lung tissue, reaching concentrations comparable to serum levels.
• The findings support the use of cefepime for treating lung infections where adequate tissue concentrations are essential.
• Population pharmacokinetic modeling provides valuable insights into cefepime's behavior in lung tissue.